Finn Myhren

Title: The Innovative Contributions of Finn Myhren

Introduction

Finn Myhren is a notable inventor based in Stamsund, Norway. He has made significant contributions to the field of marine biotechnology, particularly in the development of health-related compositions. With a total of 3 patents, Myhren's work focuses on enhancing the therapeutic potential of omega-3 fatty acids.

Latest Patents

Myhren's latest patents include a krill oil composition enriched in LPC-DHA and LPC-EPA. This invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. The invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making, and methods of using it to treat neurological and ocular disorders. Another significant patent is for lysophosphatidylcholine compositions. This invention provides marine lysophosphatidylcholine compositions for use in pharmaceuticals, nutraceuticals, and functional foods, as well as methods for making these compositions.

Career Highlights

Throughout his career, Myhren has worked with various organizations, including Aker Biomarine Human Ingredients and the University of Illinois. His work has been instrumental in advancing the understanding and application of marine-derived compounds in health and nutrition.

Collaborations

Myhren has collaborated with notable individuals in his field, including Nils Hoem and Petter-Arnt Hals. These collaborations have contributed to the development of innovative solutions in marine biotechnology.

Conclusion

Finn Myhren's contributions to the field of marine biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in health-related applications of marine resources.